On March 5, JPMorgan reduced its holding in Pharmaron (03759) by about 737,500 shares, with an average price of HK$18.1145 per share. The total transaction value amounted to approximately HK$13.36 million. Following this disposal, the firm’s latest shareholding stands at around 21.42 million shares, representing a 5.94% stake in the company.